Healthcare and Life Science
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis
UK NHS grants HRA/REC approval for PEMP study with Peterborough and Cambridge hospitalsClinical observational study investigating underlying biology of endometriosis aims to uncover causal mechanisms and new druggable targets to improve treatment outcomes Cambridge, UK, 19 May...
Artist selected to deliver new creative installation for Cambridge Cancer Research Hospital
A major public art commission has been announced today for the new Cambridge Cancer Research Hospital. Acclaimed artist Ivan Morison is working in collaboration with patients and staff to design a large scale sculpture — using clay from the East of England historic clay pits — for the f...
Cambridge Science Park submits masterplan to unlock the region's potential
Cambridge Science Park submits its masterplan for planning consent, continuing its commitment to a site that has been a cornerstone of the Cambridge phenomenon over the past 50 years. The plan is entirely privately funded, increasing built space from 2.8 million to approximately 8 milli...
When the conversation stalls
Readiness and International Engagement in Life Sciences.
The Hidden Boardroom Liability: Why Commoditized Web Hosting is Compromising Cambridgeshire Professional Services
A technical briefing for Managing Partners and IT Procurement Officers. We expose the severe operational and compliance risks associated with legacy shared-hosting architectures and outline the necessary transition to Sovereign Digital Infrastructure. ...
Securing enterprise digital sovereignty: Daryo89 Ltd Joins the Cambridge Network
Daryo89 Ltd is a boutique digital architecture and growth consultancy operating out of Cambridge. We engineer Sovereign Digital Assets, deploy zero-latency infrastructure, and execute Generative Engine Optimization (GEO) to mitigate digital liability for high-stakes professional service...
The EpiCentre expands laboratory capabilities with new advanced equipment
Haverhill, UK — [14th May 2026] — The EpiCentre announces a major enhancement to its laboratory offering with the introduction of two advanced pieces of scientific equipment: a fluorescent microscope and a quantitative PCR (qPCR) machine. The investment has been made possible through gr...
Why clinical safety should start before digital health products go live
Digital health innovation often moves quickly, but clinical safety must move with it from the beginning. For healthcare technology, safety is not simply a final compliance step; it should shape product design, user journeys, risk controls, implementation and ongoing monitoring.Many prom...
Sapphire Digital Health Advisory joins Cambridge Network
Sapphire Digital Health Advisory Ltd is pleased to join Cambridge Network as part of our commitment to collaboration, innovation and responsible digital health transformation.We are a UK-based clinical safety and digital health advisory company supporting health-tech, AI, occupational h...
Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis
Qureight’s AI-powered quantitative imaging analytics platform and services to analyse HRCT images to evaluate changes in compartment-specific lung biomarkersThe focus of these efforts will be on the quantitative assessment of change from baseline in lung fibrosisQureight’s imaging model...